OVARIAN CANCER and US: ESO

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Showing posts with label ESO. Show all posts
Showing posts with label ESO. Show all posts

Monday, May 14, 2012

ESO: e-grandround May 24th: Biomarkers and candidate therapeutics in ovarian cancer pipeline



Biomarkers and candidate therapeutics in ovarian cancer pipeline

e-grandround

Biomarkers and candidate therapeutics in ovarian cancer pipeline CME accredited

e-grandround GR197 - 24 May 2012 - 18:15-19:00 CET

Expert: Hani Gabra, Imperial College, London, United Kingdom
Discussant: Margaret Hutka, Royal Marsden Hospital, Sutton, United Kingdom

The live session starts in about 9 days

Access to the live session is open 15 minutes before the start of the session
Submit your question in advance

Thursday, January 19, 2012

5th Familial Cancer Conference - Event - ESO 07/06/2012 - 08/06/2012, Madrid, Spain



LEARNING OBJECTIVES

• To update recent advances in familial cancer
• To better define the genetic profile of these cancers and the clinical management of families and patients.
• To analyze the impact of the new technologies and their contribution to familial cancer risk.
MAIN TOPICS

• General concepts in familial cancer: genetic variants, variants of unknown significance; modifier factors; genetic counseling
• Common cancers: breast cancer and the family of breast cancer genes; selection criteria and clinical management; new treatments; colorectal cancer and prostate cancer; genetic and clinical management.
• Other hereditary syndromes: Familial pheocromocitoma; pancreatic cancer; Birt-Hogg-Dube syndrome; familial melanoma.
• Rare tumors: Fanconi anemia; Dysqueratosis congenital; genetic syndromes of the RAS/MAP pathway; li Fraumeni syndrome.
• New technologies applied to familial cancer studies: Integrative genomic analysis; cancer genome and personalized medicine; whole exome sequencing in the search of high susceptibility genes. 


CONFIRMATION OF REGISTRATION

Registration may be carried out online (
www.cnio.es/meetings). 

Registration fee is € 200. Registration and payment must be processed by 15 May 2012. After this date registration will only be available on site at the rate of € 300. The registration fee covers admission to the conference, a copy of the programme book, coffee and lunch throughout the conference as indicated in the programme.
 

Tuesday, August 10, 2010

e-ESO Online educational resource video (free) "The challenge of ovarian cancer in relapse" video/ESO



Note: requires registration (free)

e-grandround:

The challenge of ovarian cancer in relapse CME accredited

GR109 - 05 August 2010 - 18:15-19:00 CET
Expert: Eric Pujade-Lauraine, Hospital Hotel-Dieu, Paris, France
Discussant: Fedro A. Peccatori, European Institute of Oncology, Milano, Italy